Articles

ZUG, Switzerland - Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, is pleased to announce that its site in Bourgoin-Jallieu, France was recently recognized by Eli Lilly and Company as an outstanding supplier and business partner. Patheon received the Lilly Supplier Award for Excellence during an awards ceremony held at Lilly's headquarters.

Aldo Braca, President, European Operations for Patheon stated, "Relationships such as the one Patheon holds with Eli Lilly and Company are critical to our success as a company and to ensuring we give our clients the best service available. We are honored to be recognized as a key supplier for Lilly and thank the company for recognizing Patheon's efforts."

About Patheon Inc.
Patheon Inc. is a leading global provider of contract development and manufacturing services to the pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through the commercial manufacturing of a wide array of dosage forms including parenteral, solid, semi-solid and liquids. Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon's ability to integrate development and manufacturing services ensures that our customers' projects are delivered on time and meet the high standards of quality that Patheon is known for.

Patheon's integrated development and manufacturing network of 10 facilities and 7 development centers, across North America and Europe, strives to ensure that customer products can be launched timely and confidently anywhere in the world.

SOURCE: Patheon Inc.

Free Pharmaceutical Online Newsletter